pre-seed
Stage
1
Investors
About
Bolden Therapeutics develops first-in-class therapeutics aimed at increasing neurogenesis to improve outcomes in neurological diseases such as Alzheimer's, stroke recovery, and brain injury.
Explore Bolden Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.